Taken together, these experiments support the model in which SAMD1 acts as a negative regulator of PIK3IP1 in wild-type HepG2 cells, which is a negative regulator of PI3K in hepatocellular carcinoma cells [47]. This evidence concerns the gene SAMD1 and hepatocellular carcinoma.